Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease epilepsy
Symptom C0086132|depressive symptoms
Sentences 13
PubMedID- 22616163 Study on the reho in treatment-naive of temporal lobe epilepsy patients with depressive symptoms using resting functional-mri (fmri).
PubMedID- 22957244 The concept of interictal dysphoric disorder was proposed to describe the latter in response to studies suggesting that a significant portion of epilepsy patients with depressive symptoms would not have met criteria for major depressive disorder as typically described in diagnostic schedules .
PubMedID- 26076841 This pilot study was aimed at evaluating the efficacy and safety of xylaria nigripes for treating depressive symptoms in patients with epilepsy during 12 weeks of treatment.
PubMedID- 22178816 Resting-state fmri study of treatment-naive temporal lobe epilepsy patients with depressive symptoms.
PubMedID- 23153721 Emotion processing bias and age of seizure onset among epilepsy patients with depressive symptoms.
PubMedID- 25223729 The current study investigated the relative contribution of structural and functional connectivity (fc) between medial temporal (mt) and prefrontal regions in predicting levels of depressive symptoms in patients with temporal lobe epilepsy (tle).
PubMedID- 25464360 Authors' conclusions: existing evidence on the effectiveness of antidepressants in treating depressive symptoms associated with epilepsy is very limited.
PubMedID- 23521673 The incidence of depressive symptoms in patients with epilepsy is significantly higher than in the general population or in patients with other neurological disorders or chronic diseases, as shown by the majority, albeit not all, findings.
PubMedID- 24486924 Conclusion: the arabic version of the nddi-e appears to be a reliable and sensitive instrument in the identification of moderately severe or severe depressive symptoms in people with epilepsy, and it can be used with all arabic-speaking patients.
PubMedID- 21333607 The pearls program significantly reduces depressive symptoms in adults with epilepsy, and this effect is maintained for 18 months after baseline and for more than 1 year after completion of home visits.
PubMedID- 24359278 Background and aims: to investigate the relationships between demographic data, seizure-related factors, anti-epileptic drugs (aeds) taking, and depressive symptoms in patients with epilepsy (pwe), determining the major clinical risk factors of depression.
PubMedID- 26491329 At the same time, the recognition of depressive symptoms in patients with epilepsy should prompt comprehensive evaluation which ought to include assessment of depressogenic medications, not necessarily associated with nervous system at first glance.
PubMedID- 20609631 Conclusions: the pearls program, a community-integrated, home-based treatment for depression, effectively reduces depressive symptoms in adults with epilepsy and comorbid depression.

Page: 1